Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
Conditions : HR+/HER2+ Breast Cancer; Metastatic Breast Cancer Interventions : Drug: Alisertib Sponsors : University of Wisconsin, Madison Not yet recruiting
Read the full article3d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.